Devang Kantesaria serves as Executive at INOTEK PHARMACEUTICALS CORP, where they oversee executive responsibilities. Since joining the company, Devang Kantesaria has executed 3 insider transactions totaling $4.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 23, 2015 involved exercising options for 105,933 shares valued at $0.
Devang Kantesaria currently holds 2,429,543 shares of INOTEK PHARMACEUTICALS CORP (ITEK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Devang Kantesaria has been a net buyer of ITEK stock. They have purchased $4.9M and sold $0 worth of shares.
Devang Kantesaria's most recent insider trade was on Feb 23, 2015, when they sold 105,933 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 23, 2015 | ITEK | $4.9M | Purchase | 814,166 | $6.00 | Discretionary |